BUZZ-Absci gains after Morgan Stanley starts with 'overweight' rating ** Shares of Absci Corp ABSI.O rises 7.7% to $3.2 in premarket trading ** Morgan Stanley initiates coverage on the AI biologics firm with "overweight" rating and $7 price target, implying a more than twofold upside to last close ** ABSI is using its artificial intelligence and ma

BRIEF-Almirall's Ilumetri Improves Psorasis Patients' Wellbeing For Up To 1 Year June 28 (Reuters) - Almirall SA ALM.MC : ILUMETRI RESTORES AND MAINTAINS WELLBEING OF PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS TO LEVELS OF GENERAL POPULATION FOR UP TO 1 YEAR Further company coverage: ALM.MC (Gdansk Newsroom)

BRIEF-Almirall Says FDA Approves Klisyri For Actinic Keratosis Treatment On Expanded Areas June 10 (Reuters) - Almirall SA ALM.MC : FDA APPROVES KLISYRI (TIRBANIBULIN) FOR TREATMENT OF ACTINIC KERATOSIS ON EXPANDED AREA OF FACE OR SCALP UP TO 100 CM2 Source text for Workspace: ID:nCNM4dwBFR Further company coverage: ALM.MC (Gdansk Newsroom)

BRIEF-Almirall Gives Information On Dividend June 5 (Reuters) - Almirall SA ALM.MC : ISSUES IN FREED CAPITAL INCREASE IS 4 MILLION SHARES CORRESPONDING TO 1.94% OF SHARE CAPITAL FOR 488,999 EUROS SHARE CAPITAL WILL BE 25.6 MILLION EUROS, REPRESENTED BY 213,468,718 SHARES WITH PAR VALUE OF 0.12 EUROS EACH ACQUIRED 17.9 MILLION RIGHTS FOR A TOTAL GRO

EUROPE RESEARCH ROUNDUP- Alfa Laval, OMV AG, Unilever Plc May 14 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Alfa Laval, OMV AG and Unilever Plc, on Tuesday. HIGHLIGHTS * Alfa Laval ALFA.ST : JP Morgan raises target price to SEK 385 from SEK 325 * Babcock International BAB.L : Citigroup raises target price to 640p from 530p * OMV AG OMVV.VI : Morgan Stanley raises to equal weight from underweight * SKAN Group AG SKAN.S : Baader

UPDATE 1-Almirall shares rise after net profit falls less than forecast Adds share moves and analyst quote May 13 (Reuters) - Almirall ALM.MC shares surged on Monday after the Spanish pharmaceutical company's net profit fell less than expected in the first quarter and said it was seeking acquisition targets. The company said its net profit fell 4% in the quarter to 7.4 million euros ($7.97 million) on higher costs, a result which RBC said in a note was better than the 5.2 million euros expected

UPDATE 2-European shares end flat as investors await for inflation test For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Maersk shares surge fuelled by soaring freight rates OX2 jumps 40% after cash offer from EQT Updated at 1609 GMT By Ankika Biswas and Johann M Cherian May 13 (Reuters) - Europe's STOXX 600 closed flat on Monday, as investors geared up for a slew of economic data from the euro zone and a key U.S.

BUZZ-Almirall jumps after Q1 beat, guidance confirmation ** Shares in Almirall ALM.MC jump around 7% after the Spanish pharmaceutical company reported Q1 beat and stuck to its full-year guidance ** Sabadell analyst expects a positive share reaction saying EBITDA came above expectations at 53 million euros vs consensus of 48 million euros, driven by

Spanish stocks - Factors to watch on May 13 May 13 (Reuters) - The following Spanish stocks may be affected by newspaper reports and other factors on Monday . Reuters has not verified the newspaper reports, and cannot vouch for their accuracy: CAIXABANK CABK.MC Caixabank said on Friday it concluded its 500 million euro ($538.7 million) buyback programme.

Almirall confirms full-year target despite higher costs in first quarter May 13 (Reuters) - Spanish pharmaceutical company Almirall ALM.MC on Monday reiterated its profitability targets for the full-year and said it is seeking acquisition targets, even though its costs weighed on net profit in the first quarter. The company said its net profit fell 4% in the quarter to 7.4 million euros ($7.97 million) on higher costs, while earnings before interest, taxes, depreciation and amortisation rose 1.4

BRIEF-Almirall Approves Payment Of Dividend Of 39.8 Mln Euros May 13 (Reuters) - Almirall SA ALM.MC : SAID ON FRIDAY APPROVES PAYMENT OF DIVIDEND OUT OF UNRESTRICTED RESERVES OF 39.8 MILLION EUROS TO BE PAID AT LATEST ON JUNE 3 APPROVES CAPITAL INCREASE NUMBER OF FREE-OF-CHARGE ALLOCATION RIGHTS NEEDED TO RECEIVE ONE NEW SHARE IS 47 NUMBER OF NEW S

BRIEF-Almirall Says It's On Target To Meet 2024 Guidance May 13 (Reuters) - Almirall SA ALM.MC : ON TARGET TO MEET 2024 GUIDANCE CONTINUES TO EXPLORE NEW INORGANIC GROWTH OPPORTUNITIES Source text for Eikon: ID:nCNMbYlqLH Further company coverage: ALM.MC (Gdansk Newsroom)